Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/092040 stock hub

KOSDAQ/092040 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/092040is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

120.8B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/092040

In the news

Latest news · KOSDAQ/092040

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-25.4

P25 -17.1P50 0.7P75 8.5

ROIC-7.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/092040 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

KRW

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	236
Enterprise value	KRW 219.7B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7092040005
Last refreshed	2026-05-10
Market cap	KRW 120.8B
Price	KRW 1,715
Price currency	KRW
Rev Per Employee	177,887,313.98x
Sector	Healthcare
Sic	2836
Symbol	kosdaq/092040
Website	https://www.amicogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.8%
EV Earnings	-7.33x
EV/FCF	-7.81x
EV/Sales	5.23x
FCF yield	-23.28%
P/B ratio	1.13x
P/S ratio	2.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-36.62%
EBITDA Margin	-13.68%
Gross margin	12.6%
Gross Profit	KRW 5.3B
Gross Profit Growth	-89.46%
Gross Profit Growth Q	-85.31%
Gross Profit Growth3 Y	-51.29%
Gross Profit Growth5 Y	-34.7%
Net Income	KRW -30B
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-71.16%
Profit Margin	-71.36%
Profit Per Employee	KRW -126.9M
ROA	-3.65
Roa5y	-1.34
ROCE	-9.5
ROE	-25.42
Roe5y	-17.09
ROIC	-7.82
Roic5y	-2.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.82%
Cagr1y	-47.01%
Cagr3y	-41.59%
Cagr5y	-35.88%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-75.82x
Revenue Growth Q	-80.88x
Revenue Growth Years	0x
Revenue Growth3 Y	-33.74x
Revenue Growth5 Y	-18.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.16
Assets	KRW 231.9B
Cash	KRW 7.2B
Current Assets	KRW 37.9B
Current Liabilities	KRW 70.1B
Debt	KRW 94.1B
Debt Equity	KRW 0.88
Debt FCF	KRW -3.35
Equity	KRW 106.5B
Interest Coverage	-1.98
Liabilities	KRW 125.4B
Long Term Assets	KRW 194B
Long Term Liabilities	KRW 55.3B
Net Cash	KRW -86.9B
Net Cash By Market Cap	KRW -71.93
Net Debt Equity	KRW 0.82
Tangible Book Value	KRW 87.5B
Tangible Book Value Per Share	KRW 1,574
WACC	5.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.54
Inventory Turnover	3.13
Net Working Capital	KRW 523.4M
Quick ratio	0.32
Working Capital	KRW -32.2B
Working Capital Turnover	KRW -2.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.44%
Dividend per share	KRW 0
Last Dividend	KRW 25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.57%
1Y total return	-46.99%
200-day SMA	2,644.2
3Y total return	-80.07%
50-day SMA	1,631.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.16%
All Time High	31,575
All Time High Change	-94.57%
All Time High Date	2015-06-25
All Time Low	1,160
All Time Low Change	47.84%
All Time Low Date	2026-03-04
ATR	140.4
Beta	0.21
Beta1y	-0.18
Beta2y	0.08
Ch YTD	-3.76
High	1,791
High52	4,980
High52 Date	2025-06-05
High52ch	-65.56%
Low	1,644
Low52	1,160
Low52 Date	2026-03-04
Low52ch	47.85%
Ma50ch	5.1%
Price vs 200-day SMA	-35.14%
RSI	45.92
RSI Monthly	34.3
RSI Weekly	42.55
Sharpe ratio	-0.53x
Sortino ratio	-0.69
Total Return	-0.44%
Tr YTD	-3.76
Tr1m	8.48%
Tr1w	-3.54%
Tr3m	1.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -15.4B
Operating margin	-36.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,930,591%
Net Borrowing	-47,922,543,860
Shares Insiders	3.7%
Shares Institutions	0.27%
Shares Out	70,453,258
Shares Qo Q	0.96%
Shares Yo Y	0.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -28.5B
Average Volume	1,048,719.5x
Bv Per Share	1,701.1
CAPEX	KRW -3.7B
Ch10y	-88.7
Ch1m	8.48
Ch1w	-3.54
Ch1y	-46.99
Ch3m	1.3
Ch3y	-81.62
Ch5y	-90
Ch6m	-43.21
Change	0.59%
Change From Open	-0.98
Close	1,705
Days Gap	1.58
Depreciation Amortization	9,630,511,970
Dollar Volume	1,013,516,980
Earnings Date	2026-05-14
EBIT	KRW -15.4B
EBITDA	KRW -5.7B
EPS	KRW -543
F Score	2
FCF	KRW -28.1B
FCF EV Yield	-12.81x
FCF Per Share	KRW -399
Financing CF	-47,927,615,000
Fiscal Year End	December
Founded	2,000
Goodwill	1,705,064,150
Income Tax	KRW 491.2M
Investing CF	73,552,459,330
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Last Split Date	2023-12-13
Last Split Type	Forward
Ma150	2,240
Ma150ch	-23.44%
Ma20	1,889
Ma20ch	-9.21%
Net CF	137,424,000
Next Earnings Date	2026-05-14
Open	1,732
Position In Range	48.3
Ppne	154,512,145,220
Price Date	2026-05-08
Ptbv Ratio	1.38
Relative Volume	0.56x
Revenue	41,981,406,100x
SBC By Revenue	0.85x
Share Based Comp	356,384,650
Tax By Revenue	1.17x
Tr6m	-43.21%
Volume	590,972
Z Score	0.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/092040 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/092040 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/092040?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+3.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

KOSDAQ/092040 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.9

Neutral momentum band

Price vs 200-day MA

-35.1%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/092040

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/092040 stock rating?

kosdaq/092040 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/092040 analysis?

The full report lives at /stocks/kosdaq/092040/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/092040?

The latest report frames kosdaq/092040 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/092040 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.